Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg
NCT00649714
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Zonisamide Capsules 100 mg
DRUG:
Zonegran® Capsules 100 mg
Sponsor
Mylan Pharmaceuticals Inc